Several kinases and phosphatases majorly contribute to tau phosphorylation, such as glycogen synthase kinase 3β (GSK3β), cyclin-dependent kinase 5 (CDK5), mitogen-activated protein kinase (MAPK), and protein phosphatase 2A (PP2A), and are deemed potential therapeutic targets for AD [6]. Here, CDK5 is linked to Alzheimer disease.